A novel effect of rivastigmine on pre-synaptic proteins and neuronal viability in a neurodegeneration model of fetal rat primary cortical cultures and its implication in Alzheimer's disease
about
Acetylcholinesterase and Butyrylcholinesterase Inhibitory Activities of β -Carboline and Quinoline Alkaloids Derivatives from the Plants of Genus PeganumFunctional activity of the novel Alzheimer's amyloid β-peptide interacting domain (AβID) in the APP and BACE1 promoter sequences and implications in activating apoptotic genes and in amyloidogenesisRivastigmine lowers Aβ and increases sAPPα levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neuronsHuman primary mixed brain cultures: preparation, differentiation, characterization and application to neuroscience research.Functional characterization of a competitive peptide antagonist of p65 in human macrophage-like cells suggests therapeutic potential for chronic inflammation.Cognitive and affective changes in mild to moderate Alzheimer's disease patients undergoing switch of cholinesterase inhibitors: a 6-month observational study.Oxidative insults to neurons and synapse are prevented by aged garlic extract and S-allyl-L-cysteine treatment in the neuronal culture and APP-Tg mouse modelChromatographic separation of reaction products from the choline acetyltransferase and carnitine acetyltransferase assay: differential ChAT and CrAT activity in brain extracts from Alzheimer's disease versus controlsAlcohol drinking and deprivation alter basal extracellular glutamate concentrations and clearance in the mesolimbic system of alcohol-preferring (P) rats.Role of P-glycoprotein in mediating rivastigmine effect on amyloid-β brain load and related pathology in Alzheimer's disease mouse model.DL0410, a novel dual cholinesterase inhibitor, protects mouse brains against Aβ-induced neuronal damage via the Akt/JNK signaling pathway.The "aged garlic extract:" (AGE) and one of its active ingredients S-allyl-L-cysteine (SAC) as potential preventive and therapeutic agents for Alzheimer's disease (AD).Recent progress in repositioning Alzheimer's disease drugs based on a multitarget strategy.Effects of selegiline, a monoamine oxidase B inhibitor, on differentiation of P19 embryonal carcinoma stem cells, into neuron-like cells.MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed.Intravenous immunoglobulin (IVIG) treatment exerts antioxidant and neuropreservatory effects in preclinical models of Alzheimer's disease.
P2860
Q21284781-13C1A631-0C01-42EE-A3C2-5D6E8A9A8E15Q24606614-C611A74D-C315-4768-8819-A6B5C791B15EQ28479242-19620DB8-F09C-489D-B31A-C7BCED77666EQ34272943-EDF90C31-F392-432B-A704-6925AA9E7B93Q34672342-2EC10305-5875-4A17-B222-851FA847F146Q35106861-31A40F11-D060-44D9-A8D1-42F07DF19D37Q36081625-329873E7-DACC-4C64-A1BF-094B10FEBF70Q36103581-5D03974A-B8A8-484C-8B8C-276C61C56441Q36644482-64801233-A2FC-4AA2-ADAF-6D6438C6EA98Q36678091-DC86547B-5746-45E5-9946-D79A4B035FD3Q37399395-94593921-7DA9-4348-899B-9A1C830C869BQ37615989-32BC61D8-0D27-4097-95E3-598A09A37FF1Q38806779-1C88DB71-B3E3-4991-B640-8276413FA03EQ39486556-EA60A352-1B69-446E-9D3B-9620C10689DDQ41811823-C0D81982-FEE7-44DE-88D8-C4C36D12F214Q41955747-19BCC537-3233-40B2-A692-29CA2421D1FA
P2860
A novel effect of rivastigmine on pre-synaptic proteins and neuronal viability in a neurodegeneration model of fetal rat primary cortical cultures and its implication in Alzheimer's disease
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
A novel effect of rivastigmine ...... ication in Alzheimer's disease
@ast
A novel effect of rivastigmine ...... ication in Alzheimer's disease
@en
type
label
A novel effect of rivastigmine ...... ication in Alzheimer's disease
@ast
A novel effect of rivastigmine ...... ication in Alzheimer's disease
@en
prefLabel
A novel effect of rivastigmine ...... ication in Alzheimer's disease
@ast
A novel effect of rivastigmine ...... ication in Alzheimer's disease
@en
P2860
P1476
A novel effect of rivastigmine ...... ication in Alzheimer's disease
@en
P2093
Debomoy K Lahiri
Jason A Bailey
P2860
P304
P356
10.1111/J.1471-4159.2009.06490.X
P407
P577
2009-11-11T00:00:00Z